— Know what they know.
Not Investment Advice

BIB

ProShares Ultra Nasdaq Biotechnology
1W: -4.1% 1M: -9.9% 3M: +3.2% YTD: +37.8% 1Y: +75.2% 3Y: +131.1% 5Y: +9.4%
$109.80
-0.67 (-0.61%)
 
Weekly Expected Move ±5.7%
$97 $103 $110 $116 $122
ETF NASDAQ · AUM $88.9M

Portfolio Health Summary

IS Overall Score
54.8
★★★★★
Altman Z-Score
12.14
Safe
Weight Coverage
54%
of portfolio analyzed
Holdings Matched
243
with fundamental data

InsiderStreet Scorecard

★★★★★ 54.8
Profitability
52.5
Balance Sheet
55.4
Earnings Quality
53.0
Growth
55.3
Value
38.8
Momentum
65.1
Safety
80.7

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
12.14
Safe Zone (>2.99)
Piotroski F-Score
5.0 / 9
Moderate
Beneish M-Score
-1.89
Unlikely Manipulator
Credit Score
—
Earnings Quality
53.0 / 100

Portfolio Valuation

P/E
40.58x
P/B
7.89x
P/S
6.71x
EV/EBITDA
26.49x
EV/Revenue
7.29x
P/FCF
22.02x
P/OCF
19.60x
PEG
3.15x
Earnings Yield
2.46%
FCF Yield
4.54%
OCF Yield
5.10%
Median P/E
-5.03x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +29.0%
Net Income +6.8%
EPS +11.0%
FCF +21.8%
EBITDA +10.8%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +37.2%
Rev CAGR 5Y +19.6%
EPS CAGR 3Y +12.9%
EPS CAGR 5Y +11.9%
FCF CAGR 3Y +12.4%
FCF CAGR 5Y +12.3%
EBITDA CAGR 3Y -2.4%
EBITDA CAGR 5Y +2.8%
Payout Ratio
14.24%
Buyback Yield
0.97%
Dividend Yield
0.54%
Total Shareholder Return
-1.05%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$109.76
Median 1Y
$110.87
5th Pctile
$49.30
95th Pctile
$250.82
Ann. Volatility
47.7%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 40.58
Portfolio P/B 7.89
Portfolio P/S 6.71
EV/EBITDA 26.49
EV/Revenue 7.29
P/FCF 22.02
P/OCF 19.60
PEG 3.15
Earnings Yield 2.46%
FCF Yield 4.54%
OCF Yield 5.10%
Median P/E -5.03
Profitability & Returns (9)
MetricValue
Gross Margin 76.10%
Operating Margin 15.36%
Net Margin 9.78%
FCF Margin 28.17%
ROE 11.56%
ROA 4.39%
ROIC 10.19%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 1.05
Debt/Assets 0.39
Net Debt/EBITDA 1.77
Interest Coverage 4.51
Current Ratio 1.83
Quick Ratio 1.53
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 29.04%
Net Income Growth 6.79%
EPS Growth 11.02%
FCF Growth 21.76%
EBITDA Growth 10.77%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 37.21%
Revenue CAGR 5Y 19.55%
Revenue CAGR 10Y —
EPS CAGR 3Y 12.89%
EPS CAGR 5Y 11.88%
EPS CAGR 10Y —
FCF CAGR 3Y 12.44%
FCF CAGR 5Y 12.28%
FCF CAGR 10Y —
EBITDA CAGR 3Y -2.43%
EBITDA CAGR 5Y 2.75%
EBITDA CAGR 10Y —
Net Income CAGR 3Y 11.66%
Net Income CAGR 5Y 11.35%
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 54.8
IS Profitability 52.5
IS Balance Sheet 55.4
IS Earnings Quality 53.0
IS Growth 55.3
IS Value 38.8
IS Momentum 65.1
IS Safety 80.7
IS Quality 60.2
Altman Z-Score 12.14
Piotroski F-Score 4.95
Beneish M-Score -1.89
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 0.54%
Payout Ratio 14.24%
Buyback Yield 0.97%
Total Shareholder Return -1.05%
Growth Stability (4)
MetricValue
Revenue Stability 0.777
Earnings Stability 0.413
Earnings Persistence 0.652
Margin Stability 0.757
Medians (3)
MetricValue
Median P/E -5.03
Median P/B 3.49
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 54.48%
Holdings Matched 243
Total Holdings 246

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms